in 2018, it was reported that urinary fibronectin detection exhibited sensitivity of 80%, specificity of 79%, and an AUC value of 0.83, suggesting its potential as a promising non-invasive diagnostic biomarker for bladder cancer (48). Here, FN1 is linked to urinary bladder cancer.